Skip to content

met Apotheken

Active Risk: not assessed
Private limited companyfounded 2022active for 4 yearsWitte Torenwal 41, 3960 Bree, BelgiumKBO/BCE: BE 0782.370.920
Summary

met Apotheken is a financial institution. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.3m and a net result of €399,050. Equity has been growing by about 51% per year since 2022. Its solvency ranks better than 19% of 6,692 sector peers (NACE 64, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

Source: KBO
Status
Active since 18-02-2022 Normal situation
Activity
Activities of holding companies NACE 64210and 4 others
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.328.465.796 3960 Bree, since 18-02-2022
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
and 1 other

Financial position

Financial institution: outside the modelBankruptcy probability: sector outside the model
Annual accounts 2025
Profit
€399,050
▲ 6.5%
Equity
€1.3m
▲ 44.7%
Total assets
€8.0m
▲ 41.4%
Employees on 31-12-2025
4
▲ 100%
SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
9 days early
2024
22 days early
2023
22 days late
2022
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 4 accounts on average 4 days after the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 August (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Caution: Lower solvency than 81% of companies in financial servicessector median 50.8% · 6,692 companies 16.0% View
  • Positive: Equity rose in 2025from €888,685 to €1.3m ▲ 44.7% View
  • Heads a groupcompanies controlled 4 View

Recent changes

  1. · Gazette deed Appointment: A. JANS PHARMA BV (director)Permanent representative: Jans Andrea
  2. · Gazette deed IncorporationStarting capital €75,000 · Appointments: Maan Invest, Van Dijck-Voets Management and DREESEN · Permanent representatives: JANSSEN Ben, VANDIJCK Joeri and DREESEN Francesca Luc Jeanine
All 9 events

Companies linked to met Apotheken

Comparable companies

These companies have the same main activity as met Apotheken: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €4.9m and €14m, founded between 2021 and 2022.

CompanyTotal assetsGross margin
met Apotheken Bree€8.0m€0.4m
D&E WINDO Kalmthout€7.3m€0.3m
CleanHold Gent€9.1m€0.3m
DE RESE INVEST Jabbeke€6.4m€0.3m
PHARMA BIEN-ÊTRE Namur€4.9m€0.6m
ANMA Brugge€5.0m€0.6m
HD Group Lendelede€14.2m€0.5m
Full comparison

Key facts about met Apotheken

What is the company number of met Apotheken?
The company number of met Apotheken is 0782.370.920. The VAT number is the same number with BE in front: BE 0782.370.920.
Where is met Apotheken based?
The registered office is at Witte Torenwal 41, 3960 Bree.Company details
What does met Apotheken do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of met Apotheken?
The legal form of met Apotheken is Private limited company (BV).
When was met Apotheken founded?
met Apotheken was founded on 18-02-2022.
Is met Apotheken still active?
Yes, met Apotheken is an active enterprise in the KBO register.
How many employees does met Apotheken have?
met Apotheken had an average of 2.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does met Apotheken fall under?
In its 2025 annual accounts, met Apotheken states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of met Apotheken?
The turnover in financial year 2025 is ≈ €570,000. This figure is estimated from the gross margin of €434,700 and 34 comparable companies (NACE 64210). It probably lies between €480,000 and €900,000.
Is met Apotheken profitable?
In financial year 2025, met Apotheken made a profit of €399,050.
Where can I find the annual accounts of met Apotheken?
met Apotheken filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of met Apotheken due?
met Apotheken must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.